Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific Will Settle Some Transvaginal Surgical Mesh Suits For $119 Mil.

This article was originally published in The Gray Sheet

Executive Summary

The company announced April 28 that it has settled 2,970 transvaginal surgical mesh device patient lawsuits, but upwards of 25,000 cases or claims against Boston Scientific are still active.

You may also be interested in...



'Stand And Fight' Strategy Pays Off For Companies In Liability Suits

Legal analytics company Lex Machina finds that manufacturers most often win at the summary judgement stage of liability suits; however, about 96% of cases settle or are resolved procedurally.

Boston Scientific Loses Appeal Of $18.5m Pelvic Mesh Verdict

The fourth circuit court of appeals sided with plaintiffs in a product liability dispute concerning Boston Scientific's Obtryx pelvic mesh device.

Plaintiff Gets New Trial In Boston Sci Mesh Case

A Massachusetts state appeals court sent a verdict favoring the company back to the county court for reconsideration. The higher court found the judge in the original case acted improperly by keeping information relevant to mesh safety concerns from the jury.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel